Advertisement Bemis net sales rise in Q3 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Bemis net sales rise in Q3

Bemis, a supplier of flexible packaging and pressure sensitive materials used by healthcare, food, consumer products and other companies, has reported net sales of $1.29bn for the third quarter ended 30 September 2010, compared to $898.93m for the same period in 2009.

Bemis has posted a net income of $61.42m for the third quarter 2010, or $0.56 per diluted share, compared to $35.84m, or $0.33 per diluted share, for the comparable period in 2009.

For the nine months ended 30 September 2010 Bemis’ net sales were $3.59bn, compared to $2.61bn for the year ago period.

For the nine months ended 30 September 2010, Bemis has posted a net income of $151.84m, or $1.35 per diluted share, compared to $121.07m, or $1.15 per diluted share, for the year ago period.

Bemis president and CEO Henry Theisen said that so far in 2010, they have delivered double-digit growth in adjusted earnings per share compared to the record results of 2009.

"We are on track to achieve our planned acquisition related cost savings synergies in 2010 and 2011," Theisen said.

"Demand for packaging products in the Americas continues to be high, offsetting continued weakness in the European region.

"While we expect to face modest raw material cost pressures during the fourth quarter, our 2010 adjusted earnings per share guidance continues to reflect double-digit growth."